Cargando…

Flortaucipir (tau) PET in LGI1 antibody encephalitis

The contributors to persistent cognitive impairment and hippocampal atrophy in leucine‐rich glioma‐inactivated 1 antibody encephalitis (LGI1) patients are unknown. We evaluated whether tau neuropathology measured with [(18)F]flortaucipir PET neuroimaging associated with persistent cognitive impairme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Day, Gregory S., Gordon, Brian A., McCullough, Austin, Bucelli, Robert C., Perrin, Richard J., Benzinger, Tammie L. S., Ances, Beau M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886030/ https://www.ncbi.nlm.nih.gov/pubmed/33410601 http://dx.doi.org/10.1002/acn3.51297

Ejemplares similares

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study
por: O’Connor, Antoinette, et al.
Publicado: (2023)

Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
por: Makaretz, Sara J, et al.
Publicado: (2018)

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

Clinical features of limbic encephalitis with LGI1 antibody
por: Wang, Meiling, et al.
Publicado: (2017)

The Clinical Value of (18)F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody
por: Liu, Xiao, et al.
Publicado: (2020)

Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET
por: Hong, Jimin, et al.
Publicado: (2022)

Cryo-EM Structures of Chronic Traumatic Encephalopathy Tau Filaments with PET Ligand Flortaucipir
por: Shi, Yang, et al.
Publicado: (2023)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021)

Intrathecal B-cell activation in LGI1 antibody encephalitis
por: Lehmann-Horn, Klaus, et al.
Publicado: (2020)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
por: Qiao, Jianping, et al.
Publicado: (2020)

Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
por: Ludewig, Susann, et al.
Publicado: (2023)

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
por: Pontecorvo, Michael J., et al.
Publicado: (2017)

International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022)

Parametric methods for [(18)F]flortaucipir PET
por: Golla, Sandeep SV, et al.
Publicado: (2018)

Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
por: Sadaghiani, Mohammad S., et al.
Publicado: (2023)

LGI1-Antibody Associated Autoimmune Encephalitis Complicated by Primary Polydipsia
por: Yaqoob, Arjimand, et al.
Publicado: (2022)

Associations between quantitative [(18)F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
por: Timmers, Tessa, et al.
Publicado: (2019)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [(18)F]Flortaucipir PET
por: Risacher, Shannon L., et al.
Publicado: (2018)

Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis
por: Li, Tao‐Ran, et al.
Publicado: (2021)

Striatum Involvement in LGI1 Limbic Encephalitis
por: Plantone, Domenico
Publicado: (2018)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020)

GABA(A) receptor and LGI1 antibody encephalitis in a patient with thymoma
por: Simabukuro, Mateus Mistieri, et al.
Publicado: (2015)

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
por: Aurangzeb, Sidra, et al.
Publicado: (2017)

IVIG treatment for repeated hypothermic attacks associated with LGI1 antibody encephalitis
por: Hayashi, Yuichi, et al.
Publicado: (2017)

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021)

Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
por: Pontecorvo, Michael J., et al.
Publicado: (2020)

Longitudinal Tau PET Using (18)F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters
por: Visser, Denise, et al.
Publicado: (2023)

Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment
por: Mundada, Nidhi S., et al.
Publicado: (2023)

Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Liu, Yu, et al.
Publicado: (2023)

Hyponatraemia caused by LGI1-associated limbic encephalitis
por: McQuillan, Rory F., et al.
Publicado: (2011)

Pilomotor Seizures in a Patient With LGI1 Encephalitis
por: Yang, Jinxia, et al.
Publicado: (2020)

LGI1 Encephalitis: Autoimmune Epilepsy or Movement Disorder
por: Jagtap, Sujit A., et al.
Publicado: (2023)

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
por: Chen, Charles D., et al.
Publicado: (2023)

Unsupervised [(18)F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
por: Quattrini, Giulia, et al.
Publicado: (2023)

Regional [(18)F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
por: Wolters, Emma E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mblqu9qc57kmm5jh13u997nco